NDC 31260-402 - SUCRALFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 31260-402
- Package NDCs from labels
- 31260-402-01, 31260-402-02
- Manufacturer
- Gulbrandsen Technologies India Private Limited
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SUCRALFATE - Gulbrandsen Technologies India Private Limited | Gulbrandsen Technologies India Private Limited | 2026-04-03 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 31260-402-01 | SUCRALFATE | 25 kg in 1 DRUM | POWDER | 25 | 3 | |
| 31260-402-02 | SUCRALFATE | 0.5 kg in 1 CONTAINER | POWDER | 0.5 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 2687d670-8af6-42a2-9081-fee112e80fc0 | 2023-05-24 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 370f5ac6-2c64-42ef-ab5d-075a473012f1 | 2023-05-22 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | A-S Medication Solutions | 03b66f88-d346-4260-867c-c942c4c68a79 | 2023-05-02 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Aphena Pharma Solutions - Tennessee, LLC | b414dc07-681c-4fde-965f-09df64c015e7 | 2021-05-19 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Mylan Pharmaceuticals, Inc. | ae58c382-c1cf-4ebf-9c97-bdff0682df8b | 2020-06-12 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Aphena Pharma Solutions - Tennessee, LLC | 84447e21-e311-4e9f-9065-53956e90135c | 2019-04-22 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Teva Pharmaceuticals USA, Inc. | c7a43df7-eb37-4273-9250-87953b1fd270 | 2015-09-01 | Adverse reactions | XX73205DH5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.